Creative Medical Technology Holdings, Inc. Payments to Acquire Businesses, Gross
Creative Medical Technology Holdings, Inc. (CELZ) reported Payments to Acquire Businesses, Gross of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2022-03-30
- Creative Medical Technology Holdings, Inc. payments to acquire businesses, gross for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Creative Medical Technology Holdings, Inc. payments to acquire businesses, gross for fiscal 2020 was $250.00K.
| Period end | Payments to Acquire Businesses, Gross 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2020-12-31 | $250.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |